Procalcitonin in acute cardiac patients

Internal and Emergency Medicine

Volumn 6, Issue 3, 2011, Pages 245-252

  Picariello, Claudio ^a   Lazzeri, Chiara ^a   Valente, Serafina ^a   Chiostri, Marco ^a   Gensini, Gian Franco ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Acute coronary syndromes; Bacterial infection; Cardiogenic shock; Procalcitonin; Sepsis

Indexed keywords

EID: 85027952336     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-010-0462-x     Document Type: Review

References (49)

1. Moya F, Nieto A, R-Candela JL (1975) Calcitonin biosynthesis: evidence for a precursor. Eur J Biochem 55(2): 407-413.
2. Assicot M, Gendrel D, Carsin H, Raymond J, Guillbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341(8844): 515-518.
3. Maruna P, Nedelníková K, Gürlich R (2000) Physiology and genetics of procalcitonin. Physiol Res 49(Suppl 1): S57-S61 (review).
4. Schneider HG, Lam QT (2007) Procalcitonin for the clinical laboratory: a review. Pathology 39(4): 383-390.
5. Müller B, Becker KL (2001) Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly 131(41-42): 595-602.
6. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C (1994) Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79(6): 1605-1608.
7. de Werra I, Jaccard C, Corradin SB, Chioléro R, Yersin B, Gallati H, Assicot M, Bohuon C, Baumgartner JD, Glauser MP, Heumann D (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25(4): 607-613.
8. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schüttler J (1998) Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 24(7): 680-684.
9. Abbasi A, Corpeleijn E, Postmus D, Gansevoort RT, de Jong PE, Gans RO, Struck J, Hillege HL, Stolk RP, Navis G, Bakker SJ (2010) Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome. J Clin Endocrinol Metab Jun 9 [Epub ahead of print].
10. Lacour AG, Gervaix A, Zamora SA, Vadas L, Lombard PR, Dayer JM, Suter S (2001) Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur J Pediatr 160(2): 95-100.
11. de Kruif MD, Limper M, Gerritsen H, Spek CA, Brandjes DP, ten Cate H, Bossuyt PM, Reitsma PH, van Gorp EC (2010) Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department. Crit Care Med 38(2): 457-463.
12. Ingram PR, Inglis T, Moxon D, Speers D (2010) Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care Med Jan 13 [Epub ahead of print].
13. Eisenhut M (2010) Use of procalcitonin measurement to identify bacterial co-infection in patients with H1N1 influenza. Acta Paediatr Jan 8 [Epub ahead of print] No abstract available.
14. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K et al (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36: 296-327.
15. Riché FC, Cholley BP, Panis YH, Laisné MJ, Briard CG, Graulet AM, Guéris JL, Valleur PD (2000) Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis. Crit Care Med 28(2): 433-437.
16. Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, Müller C, Huber P, Müller B, Tamm M (2007) Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 131(1): 9-19.
17. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B (2009) ProHOSP Study Group Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302(10): 1059-1066.
18. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M; for the PRORATA trial group (2010) Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet Jan 22 [Epub ahead of print].
19. Aouifi A, Piriou V, Blanc P, Bouvier H, Bastien O, Chiari P, Rousson R, Evans R, Lehot JJ (1999) Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anaesth 83(4): 602-607.
20. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY (2006) Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34(7): 1996-2003.
21. Tang BM, Eslick GD, Craig JC, McLean AS (2007) Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7(3): 210-217 (review).
22. Jensen JU, Lundgren B, Hein L, Mohr T, Petersen PL, Andersen LH, Lauritsen AO et al (2008) The Procalcitonin, Survival Study (PASS)--a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker procalcitonin, pro-active diagnostic, therapeutic responses to abnormal procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients. BMC Infect Dis 8: 91.
23. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M (2006) Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 34: 2596-2602.
24. Rau BM, Frigerio I, Buchler MW, Wegscheider K, Bassi C, Puolakkainen PA, Beger HG, Schilling MK (2007) Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg 142: 134-142.
25. Luyt CE, Combes A, Reynaud C, Hekimian G, Nieszkowska A, Tonnellier M, Aubry A, Trouillet JL, Bernard M, Chastre J (2008) Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 34: 1434-1440.
26. Charles PE, Kus E, Aho S, Prin S, Doise JM, Olsson NO, Blettery B, Quenot JP (2009) Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report. BMC Infect Dis 9: 49.
27. Hausfater P, Brochet C, Freund Y, Charles V, Bernard M (2010) Procalcitonin measurement in routine emergency medicine practice: comparison between two immunoassays. Clin Chem Lab Med 48: 501-504.
28. Schuetz P, Christ-Crain M, Huber AR, Müller B (2010) Long-term stability of procalcitonin in frozen samples and comparison of Kryptor and VIDAS automated immunoassays. Clin Biochem 43: 341-4 [Epub 2009 Sep 9].
29. Kafkas N, Venetsanou K, Patsilinakos S, Voudris V, Antonatos D, Kelesidis K, Baltopoulos G, Maniatis P, Cokkinos DV (2008) Procalcitonin in acute myocardial infarction. Acute Card Care 10: 30-36.
30. Geppert A, Steiner A, Delle-Karth G, Heinz G, Huber K (2003) Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med 29: 1384-1389.
31. Buratti T, Ricevuti G, Pechlaner C, Joannidis M, Wiedermann FJ, Gritti D, Herold M, Wiedermann CJ (2001) Plasma levels of procalcitonin and interleukin-6 in IMA. Inflammation 25: 97-100.
32. Remskar M, Horvat M, Hojker S, Noc M (2002) Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr 114: 205-210.
33. Sentürk T, Cordan J, Baran I, Ozdemir B, Güllülü S, Aydinlar A, Göral G (2007) Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease. Acta Cardiol 62: 135-141.
34. Picariello C, Lazzeri C, Chiostri M, Gensini G, Valente S (2009) Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention. Intern Emerg Med 4: 403-408.
35. Biasucci LM, Biasillo G, Stefanelli A (2009) Procalcitonin and acute coronary syndromes: a new biomarker for an old disease. Intern Emerg Med 29(4): 363-365.
36. Brunkhorst FM, Clark AL, Forycki ZF, Anker SD (1999) Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation. Int J Cardiol 72(1): 3-10.
37. Sponholz C, Sakr Y, Reinhart K, Brunkhorst F (2006) Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care Med 10(5): R145.
38. Boeken U, Feindt P, Petzold T, Klein M, Micek M, Seyfert UT, Mohan E, Schulte HD, Gams E (1998) Diagnostic value of procalcitonin: the influence of cardiopulmonary bypass, aprotinin, SIRS, and sepsis. Thorac Cardiovasc Surg 46(6): 348-351.
39. Prat C, Ricart P, Ruyra X, Domínguez J, Morillas J, Blanco S, Tomasa T, Torres T, Cámara L, Molinos S, Ausina V (2008) Serum concentration of procalcitonin after cardiac surgery. J Card Surg 23(6): 627-632.
40. Adamik B, Kübler-Kielb J, Golebiowska B, Gamian A, Kübler A (2000) Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin and procalcitonin: correlation with mortality and postoperative complications. Intensive Care Med 26(9): 1259-1567.
41. Madershahian N, Wittwer T, Strauch J, Wippermann J, Rahmanian P, Franke UF, Wahlers T (2008) Kinetic of procalcitonin in the early postoperative course following heart transplantation. J Card Surg 23(5): 468-473.
42. Picariello C, Lazzeri C, Chiostri M, Gensini GF, Valente S (2010) Kinetic of procalcitonin in patients with cardiogenic shock following acute myocardial infarction: preliminary data. HSR Proceeding, in press.
43. Molnár Z, Bogár L (2006) Let's go dynamic with procalcitonin!. Crit Care Med 34(10): 2687-2688.
44. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M (2006) Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 34(10): 2596-2602.
45. Wan S, LeClerc JL, Vincent JL (1997) Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 112: 676-692.
46. Kirklin JK, Westaby S, Blackstone EH et al (1983) Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 86: 845-857.
47. Rocke DA, Gaffin SL, Wells MT et al (1987) Endotoxemia associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg 93: 832-837.
48. Franke A, Lante W, Fackeldey V et al (2005) Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: Is what we see what we know? Eur J CardiothoracSurg 28: 569-575.
49. Jereb M, Kotar T, Jurca T, LejkoZupanc T (2009) Usefulness of procalcitonin for diagnosis of infective endocarditis. Intern Emerg Med 4: 221-226.